South Korea
# |
Name |
Price to Earnings Ratio (P/E) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
1,537.30 |
Jan. 14, 2025 | USD 17.02 | -2.20% |
|
South Korea |
|
2 |
149.79 |
Jan. 14, 2025 | USD 33.55 | -1.07% |
|
South Korea |
|
3 |
127.18 |
Jan. 14, 2025 | USD 5.79 | -4.44% |
|
South Korea |
|
4 |
105.20 |
Jan. 14, 2025 | USD 10.90 | 0.42% |
|
South Korea |
|
5 |
100.54 |
Jan. 14, 2025 | USD 38.12 | 0.02% |
|
South Korea |
|
6 |
80.34 |
Jan. 14, 2025 | USD 61.65 | 0.74% |
|
South Korea |
|
7 |
75.61 |
Jan. 14, 2025 | USD 698.37 | 1.93% |
|
South Korea |
|
8 |
71.84 |
Jan. 14, 2025 | USD 83.61 | 0.82% |
|
South Korea |
|
9 |
64.89 |
Jan. 14, 2025 | USD 125.83 | 1.12% |
|
South Korea |
|
10 |
38.18 |
Jan. 14, 2025 | USD 36.83 | -2.69% |
|
South Korea |
|
11 |
34.32 |
Jan. 14, 2025 | USD 1.73 | 1.34% |
|
South Korea |
|
12 |
17.13 |
Jan. 14, 2025 | USD 5.07 | 0.47% |
|
South Korea |
|
13 |
16.32 |
Jan. 14, 2025 | USD 8.54 | 0.34% |
|
South Korea |
|
14 |
16.25 |
Jan. 14, 2025 | USD 7.15 | 4.63% |
|
South Korea |
|
15 |
15.28 |
Jan. 14, 2025 | USD 19.95 | 0.05% |
|
South Korea |
|
16 |
14.74 |
Jan. 14, 2025 | USD 1.22 | 1.14% |
|
South Korea |
|
17 |
12.86 |
Jan. 14, 2025 | USD 11.69 | 2.23% |
|
South Korea |
|
18 |
11.47 |
Jan. 14, 2025 | USD 14.32 | 2.94% |
|
South Korea |
|
19 |
9.94 |
Jan. 14, 2025 | USD 11.90 | 0.22% |
|
South Korea |
|
20 |
9.89 |
Jan. 14, 2025 | USD 16.30 | -3.69% |
|
South Korea |
|
21 |
9.32 |
Jan. 14, 2025 | USD 68.20 | 0.14% |
|
South Korea |
|
22 |
7.12 |
Jan. 14, 2025 | USD 4.46 | 2.14% |
|
South Korea |
|
23 |
6.39 |
Jan. 14, 2025 | USD 1.81 | 1.70% |
|
South Korea |
|
24 |
5.80 |
Jan. 14, 2025 | USD 1.83 | 0.74% |
|
South Korea |
|
25 |
5.26 |
Jan. 14, 2025 | USD 7.40 | 0.83% |
|
South Korea |
|
26 |
3.14 |
Jan. 14, 2025 | USD 24.38 | 0.88% |
|
South Korea |
|
27 |
1.69 |
Jan. 14, 2025 | USD 11.90 | 21.74% |
|
South Korea |
|
28 |
-1.15 |
Jan. 14, 2025 | USD 4.71 | 1.18% |
|
South Korea |
|
29 |
-1.25 |
Jan. 14, 2025 | USD 1.17 | -3.48% |
|
South Korea |
|
30 |
-1.39 |
Jan. 14, 2025 | USD 0.38 | 0.74% |
|
South Korea |
|
31 |
-1.74 |
Jan. 14, 2025 | USD 1.92 | -0.32% |
|
South Korea |
|
32 |
-2.18 |
Jan. 14, 2025 | USD 1.67 | -1.86% |
|
South Korea |
|
33 |
-2.67 |
Jan. 14, 2025 | USD 7.85 | -1.23% |
|
South Korea |
|
34 |
-3.13 |
Jan. 14, 2025 | USD 3.70 | 0.18% |
|
South Korea |
|
35 |
-3.29 |
Jan. 14, 2025 | USD 1.63 | 0.95% |
|
South Korea |
|
36 |
-3.38 |
Jan. 14, 2025 | USD 1.27 | -0.44% |
|
South Korea |
|
37 |
-3.68 |
Jan. 14, 2025 | USD 3.10 | -1.75% |
|
South Korea |
|
38 |
-4.51 |
Jan. 14, 2025 | USD 15.31 | 0.29% |
|
South Korea |
|
39 |
-6.48 |
Jan. 14, 2025 | USD 6.10 | 8.89% |
|
South Korea |
|
40 |
-8.50 |
Jan. 14, 2025 | USD 2.84 | -1.97% |
|
South Korea |
|
41 |
-8.91 |
Jan. 14, 2025 | USD 3.90 | -0.31% |
|
South Korea |
|
42 |
-11.22 |
Jan. 14, 2025 | USD 1.03 | 0.60% |
|
South Korea |
|
43 |
-11.23 |
Jan. 14, 2025 | USD 10.34 | -1.02% |
|
South Korea |
|
44 |
-12.69 |
Jan. 14, 2025 | USD 10.57 | -0.48% |
|
South Korea |
|
45 |
-16.04 |
Jan. 14, 2025 | USD 1.84 | -0.37% |
|
South Korea |
|
46 |
-17.34 |
Jan. 14, 2025 | USD 4.09 | 4.76% |
|
South Korea |
|
47 |
-18.02 |
Jan. 14, 2025 | USD 0.95 | -1.80% |
|
South Korea |
|
48 |
-28.66 |
Jan. 14, 2025 | USD 8.48 | -0.62% |
|
South Korea |
|
49 |
-35.88 |
Jan. 14, 2025 | USD 17.25 | 0.74% |
|
South Korea |
|
50 |
-36.94 |
Jan. 14, 2025 | USD 9.81 | 0.60% |
|
South Korea |
The Biotechnology company in South Korea with the highest Price to Earnings Ratio (P/E) is Seegene, Inc. (KOSDAQ: 096530.KQ) at 1,537.30.
The Biotechnology company in South Korea with the lowest Price to Earnings Ratio (P/E) is ALTEOGEN Inc. (KOSDAQ: 196170.KQ) at -4,288.39.
The top 10 Biotechnology companies in South Korea by Price to Earnings Ratio (P/E) are Seegene, Inc., SK bioscience Co.,Ltd., Pharmicell Co., Ltd., i-SENS, Inc., Celltrion Pharm, Inc., ST Pharm Co.,Ltd., Samsung Biologics Co.,Ltd., Medy-Tox Inc., Celltrion, Inc. and Dong-A ST Co., Ltd..
The bottom 10 Biotechnology companies in South Korea by Price to Earnings Ratio (P/E) are ALTEOGEN Inc., ABL Bio Inc., SK Biopharmaceuticals Co., Ltd., HLB Life Science Co., Ltd., Peptron, Inc., Chabiotech Co.,Ltd., Green Cross Corporation, Anterogen.Co.,Ltd., FutureChem Co.,Ltd and Bioneer Corporation.